Pre-Emptive Comparative Study of the Effect of Intravenous Apotel® and Ketorolac on Pain after Laparoscopic Cholecystectomy Surgery under General Anesthesia: Triple-Blinded Clinical Trial

Laparoscopic cholecystectomy has been accepted as a safe and gold-standard procedure in the world and has many advantages. However, one of the common complications after laparoscopic cholecystectomy is chronic and sometimes very severe pain. Considering the patients' need to control postoperative pain with drugs that have the least possible side effects, as well as limited studies on the effect of painkillers on pain caused by laparoscopic cholecystectomy, the purpose of this study is to compare the preemptive effect of two drugs. Apotel and ketorolac were used for the first time in patients undergoing laparoscopic cholecystectomy.

This study was conducted as a three-blind randomized clinical trial on 90 patients aged 18 to 68 years, with ASA class one and two, who underwent general anesthesia for cholecystectomy.

The findings of this study show generally, the need for narcotics after cholecystectomy surgery in patients under anesthesia with ketorolac was less than in Apotel and the control group. These findings were also confirmed in patients' pain intensity and patients' satisfaction, so patients' satisfaction in Ketorolac and then Apotel group was higher compared to the control group, which is in line with previous studies in this field.

Therefore, it seems that the overall need for narcotics was lower in the ketorolac group than in Apotel and lower in Apotel than in control.